Distributed acoustic sensing (DAS) technology utilizes fiber optic cables, with advances in photonics and signal processing enabling the measurement of acoustic and seismic disturbances along the entire length of an optical fiber. It has found widespread applications in oil and gas industry for pipeline monitoring, leakage detection, seismic surveys, and security monitoring. The DAS systems are deployed along oil and gas pipelines to monitor vibrations and detect any damage or leaks in real-time. They provide a continuous stream of high-resolution data to operators, enabling prevention of environmental damages and threats. DAS technology ensures safety and integrity of pipeline infrastructure while improving operational efficiencies for oil and gas companies. The global Distributed Acoustic Sensing (DAS) Market is estimated to be valued at US$ 701.1 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The growth of the global distributed acoustic sensing market size is majorly driven by the wide adoption of DAS technology in continuous monitoring of oil and gas pipelines. DAS systems provide 24/7 surveillance of pipelines from a centralized control room and help operators detect any disturbances occurring along the pipelines in real-time. They eliminate the need for costly pigging operations and ensure early leak detection. This increases the safety and integrity of pipeline infrastructure while minimizing environmental disasters. Another major driver is the ability of DAS to simultaneously monitor multiple pipelines and field assets using a single optical cable, reducing overall operational and maintenance costs for oil and gas companies.
The distributed acoustic sensing (DAS) market is dominated by the healthcare segment. Healthcare accounts for over 60% share of the total DAS market as it is widely used in blood coagulation testing and platelet aggregation monitoring. DAS helps conduct several diagnostic tests to analyze coagulation disorders. The growing prevalence of cardiovascular diseases and rising geriatric population prone to coagulation disorders is driving the demand for DAS systems in healthcare facilities.
Political: Governments across countries are increasing healthcare expenditure to modernize facilities and invest in new diagnostic technologies like DAS. Favorable regulations have promoted adoption of DAS systems in developed markets.
Economic: Rising disposable income is allowing more people to opt for advanced diagnostic tests aided by DAS. The global economic recovery post pandemic is stimulating investments in healthcare infrastructure and new diagnostic products.
Social: Growing health awareness and better access to healthcare are driving preventive health checks. The increasing focus on early detection of diseases is propelling the demand for accurate diagnostic systems like DAS in hospitals and clinics.
Technological: Continuous technological advancements are making DAS systems more compact, reliable and affordable. New applications are being explored across different fields like industrial testing and R&D. Integration of AI and machine learning is helping analyze large volumes of DAS data faster.
The global distributed acoustic sensing (DAS) market is expected to witness high growth in the coming years.
Regional analysis: Asia Pacific is projected to be the fastest growing region in the distributed acoustic sensing market during the forecast period. This can be attributed to increasing healthcare spending, rising medical tourism, and growing penetration of advanced diagnostic technologies across major Asian countries like China and India. Besides, growing collaborations between global players and local Asian companies is enhancing the accessibility of DAS systems within the region.
Key players: Key players operating in the distributed acoustic sensing (DAS) market are Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd. Lepu Medical Technology and Render Biotech Co. have strong product portfolios for blood coagulation testing using DAS technology.